These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7825460)

  • 1. Mucosal immunity and strategies for novel microbial vaccines.
    Mestecky J; Moldoveanu Z; Novak M; Compans RW
    Acta Paediatr Jpn; 1994 Oct; 36(5):537-44. PubMed ID: 7825460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for human mucosal vaccines.
    Mestecky J; McGhee JR
    Adv Exp Med Biol; 1992; 327():13-23. PubMed ID: 1295333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common mucosal immune system and current strategies for induction of immune responses in external secretions.
    Mestecky J
    J Clin Immunol; 1987 Jul; 7(4):265-76. PubMed ID: 3301884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting and controlled release of antigens for the effective induction of secretory antibody responses.
    Mestecky J; Eldridge JH
    Curr Opin Immunol; 1991 Aug; 3(4):492-5. PubMed ID: 1755973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccination strategies for the control of mucosal infection.
    Husband AJ
    Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR; Mestecky J
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives in vaccine development: mucosal immunity to infections.
    McGhee JR; Kiyono H
    Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The development of mucosal vaccine using bacterial function for targeting mucosal tissues].
    Suzuki H; Kondoh M; Yagi K; Kiyono H; Kunisawa J
    Yakugaku Zasshi; 2014; 134(5):629-34. PubMed ID: 24790045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
    Kiyono H; Bienenstock J; McGhee JR; Ernst PB
    Reg Immunol; 1992; 4(2):54-62. PubMed ID: 1503889
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
    Corthésy B; Bioley G
    Front Immunol; 2018; 9():431. PubMed ID: 29563912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
    Czerkinsky C; Holmgren J
    Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female genital tract immunity: distinct immunological challenges for vaccine development.
    Naz RK
    J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Strategies for Mucosal Vaccination.
    Longet S; Lundahl MLE; Lavelle EC
    Bioconjug Chem; 2018 Mar; 29(3):613-623. PubMed ID: 29300463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucosal immunity].
    van der Heijden PJ; Bianchi AT
    Tijdschr Diergeneeskd; 1990 Nov; 115(22):1058-64. PubMed ID: 2256097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies of immunization against mucosal infections.
    Russell MW; Martin MH; Wu HY; Hollingshead SK; Moldoveanu Z; Mestecky J
    Vaccine; 2000 Dec; 19 Suppl 1():S122-7. PubMed ID: 11163475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.